Search research articles
Contact Us
Filters
Showing results (11-20 of 162) with videos related to
Page
of 17
Sort By:
The New England Journal of Medicine
|
April 2, 2010
MMP12, lung function, and COPD in high-risk populations
Paul T Elkington, Graham S Cooke
Current Opinion in Infectious Diseases
|
December 3, 2019
Interventions to reduce acute hepatitis C virus in HIV-positive MSM
Tamara Elliott, Graham S Cooke, Lucy Garvey
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Genotype 4 and the global challenge of hepatitis C treatment
Stephen Ryder, Sarah Pett, Graham S Cooke
The Lancet. Global Health
|
August 1, 2019
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis
Bryony Simmons, Graham S Cooke, Marisa Miraldo
BMJ (Clinical Research Ed.)
|
January 7, 2010
Treatment for hepatitis B
Graham S Cooke, Janice Main, Mark R Thursz
F1000Research
|
September 24, 2020
Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable
Tom A Yates, Graham S Cooke, Peter MacPherson
AIDS (London, England)
|
May 11, 2021
Identification of hepatitis delta superinfection when investigating transaminitis in HIV/hepatitis B virus co-infection
Ali Hamady, Graham S Cooke, Lucy J Garvey
Tropical Medicine & International Health : TM & IH
|
October 22, 2009
Hepatitis B treatment in resource poor settings: time for action
Mark Thursz, Graham S Cooke, Andrew J Hall
The Lancet. Infectious Diseases
|
March 21, 2008
HIV and hepatitis B co-infection in Africa
Richard J Lessells, Janice Main, Graham S Cooke
The Lancet. Gastroenterology & Hepatology
|
November 1, 2019
Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission
John W Ward, Stefan Z Wiktor, Graham S Cooke
Page
of 17
Search research articles
Search
Showing results (11-20 of 162) with videos related to
Sort By:
Page
of 17
The New England Journal of Medicine
|
April 2, 2010
MMP12, lung function, and COPD in high-risk populations
Paul T Elkington, Graham S Cooke
Current Opinion in Infectious Diseases
|
December 3, 2019
Interventions to reduce acute hepatitis C virus in HIV-positive MSM
Tamara Elliott, Graham S Cooke, Lucy Garvey
The Lancet. Gastroenterology & Hepatology
|
April 14, 2017
Genotype 4 and the global challenge of hepatitis C treatment
Stephen Ryder, Sarah Pett, Graham S Cooke
The Lancet. Global Health
|
August 1, 2019
Effect of voluntary licences for hepatitis C medicines on access to treatment: a difference-in-differences analysis
Bryony Simmons, Graham S Cooke, Marisa Miraldo
BMJ (Clinical Research Ed.)
|
January 7, 2010
Treatment for hepatitis B
Graham S Cooke, Janice Main, Mark R Thursz
F1000Research
|
September 24, 2020
Rational use of SARS-CoV-2 polymerase chain reaction tests within institutions caring for the vulnerable
Tom A Yates, Graham S Cooke, Peter MacPherson
AIDS (London, England)
|
May 11, 2021
Identification of hepatitis delta superinfection when investigating transaminitis in HIV/hepatitis B virus co-infection
Ali Hamady, Graham S Cooke, Lucy J Garvey
Tropical Medicine & International Health : TM & IH
|
October 22, 2009
Hepatitis B treatment in resource poor settings: time for action
Mark Thursz, Graham S Cooke, Andrew J Hall
The Lancet. Infectious Diseases
|
March 21, 2008
HIV and hepatitis B co-infection in Africa
Richard J Lessells, Janice Main, Graham S Cooke
The Lancet. Gastroenterology & Hepatology
|
November 1, 2019
Launch of the Coalition for Global Hepatitis Elimination: a recommendation of the Lancet Gastroenterology & Hepatology Commission
John W Ward, Stefan Z Wiktor, Graham S Cooke
Page
of 17